This federal contract award, valued at $2,208.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order with a firm fixed price, and the ultimate completion date is November 18, 2024. The contract does not have a set-aside designation. Cepheid is a prime contractor that has been awarded multiple federal contracts and grants, including indefinite delivery vehicles (IDVs)...
This federal contract award, valued at $1,730.40, was issued by the Medical Supply Chain component of the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger vehicle, with a firm fixed price pricing type and an ultimate completion date of July 24, 2024. Cepheid is the prime contractor and will provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
The U.S. government agency, the Defense Logistics Agency (DLA), has awarded a $1,605 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, which does not have a set-aside designation, is for the provision of diagnostic testing equipment, reagents, consumables, and associated maintenance and support services. This award is part of Cepheid's portfolio of federal contracts, which includes indefinite delivery vehicles (IDVs)...
This federal contract award, valued at $5,530.08, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order with a firm fixed price and an ultimate completion date of November 13, 2024. The award does not have a set-aside designation, indicating Cepheid was the prime contractor selected. Based on the description, this contract is likely part of the Department of...
This federal contract award, valued at $10,200.00, was issued by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is a delivery order with a firm fixed-price pricing type, and does not have any set-aside designation. The award is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of various...
This federal contract award, valued at $9,450.12, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The award is a delivery order contract with a firm fixed price pricing type, with a completion date of January 29, 2025. The contract does not have a set-aside designation. Cepheid, based in Sunnyvale, California, is a prime contractor that provides molecular diagnostic testing solutions, including GeneXpert diagnostic...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $3,567.40 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, awarded on May 20, 2024, is for the provision of medical supply chain items, with a completion date of June 4, 2024. The contract does not have a set-aside designation. Cepheid is a leading provider of molecular diagnostic equipment, reagents, and consumables to federal agencies,...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has an award value of $5,440.00 and is a firm fixed-price delivery order. Cepheid will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, and test kits, to support the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...